EUA
NxTAG CoV Extended Panel Assay
FDA Emergency Use Authorization · Luminex Molecular Diagnostics, Inc. · Oct 19, 2022
Key facts
| Product | NxTAG CoV Extended Panel Assay |
|---|---|
| Company | Luminex Molecular Diagnostics, Inc. |
| Product type | RT-PCR, Multiple Targets |
| Date | Oct 19, 2022 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: